• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

韩国一项多中心队列研究:预测 COVID-19 肺炎患者发生 ARDS 的危险因素和评分系统。

Risk Factors and a Scoring System to Predict ARDS in Patients with COVID-19 Pneumonia in Korea: A Multicenter Cohort Study.

机构信息

Department of Internal Medicine, College of Medicine, Chosun University, Gwangju, Republic of Korea.

Department of Infectious Diseases, Chonnam National University Hospital, Gwangju, Republic of Korea.

出版信息

Dis Markers. 2021 Apr 9;2021:8821697. doi: 10.1155/2021/8821697. eCollection 2021.

DOI:10.1155/2021/8821697
PMID:33897912
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8052177/
Abstract

Predictive studies of acute respiratory distress syndrome (ARDS) in patients with coronavirus disease 2019 (COVID-19) are limited. In this study, the predictors of ARDS were investigated and a score that can predict progression to ARDS in patients with COVID-19 pneumonia was developed. All patients who were diagnosed with COVID-19 pneumonia between February 1, 2020, and May 15, 2020, at five university hospitals in Korea were enrolled. Their demographic, clinical, and epidemiological characteristics and the outcomes were collected using the World Health Organization COVID-19 Case Report Form. A logistic regression analysis was performed to determine the predictors for ARDS. The receiver operating characteristic (ROC) curves were constructed for the scoring model. Of the 166 patients with COVID-19 pneumonia, 37 (22.3%) patients developed ARDS. The areas under the curves for the infiltration on a chest X-ray, C-reactive protein, neutrophil/lymphocyte ratio, and age, for prediction of ARDS were 0.91, 0.90, 0.87, and 0.80, respectively (all < 0.001). The COVID-19 ARDS Prediction Score (CAPS) was constructed using age (≥60 years old), C-reactive protein (≥5 mg/dL), and the infiltration on a chest X-ray (≥22%), with each predictor allocated 1 point. The area under the curve of COVID-19 ARDS prediction score (CAPS) for prediction of ARDS was 0.90 (95% CI 0.86-0.95; < 0.001). It provided 100% sensitivity and 75% specificity when the CAPS score cutoff value was 2 points. CAPS, which consists of age, C-reactive protein, and the area of infiltration on a chest X-ray, was predictive of the development of ARDS in patients with COVID-19 pneumonia.

摘要

预测研究表明,2019 年冠状病毒病(COVID-19)患者发生急性呼吸窘迫综合征(ARDS)的情况有限。在这项研究中,我们调查了 ARDS 的预测因素,并制定了一个可以预测 COVID-19 肺炎患者进展为 ARDS 的评分。

所有在 2020 年 2 月 1 日至 2020 年 5 月 15 日期间在韩国五所大学医院被诊断为 COVID-19 肺炎的患者均被纳入研究。使用世界卫生组织 COVID-19 病例报告表收集了他们的人口统计学、临床和流行病学特征以及结局。

采用逻辑回归分析确定 ARDS 的预测因素。构建评分模型的受试者工作特征(ROC)曲线。在 166 例 COVID-19 肺炎患者中,37 例(22.3%)患者发生 ARDS。

胸部 X 线浸润、C 反应蛋白、中性粒细胞/淋巴细胞比值和年龄预测 ARDS 的曲线下面积分别为 0.91、0.90、0.87 和 0.80(均<0.001)。

使用年龄(≥60 岁)、C 反应蛋白(≥5mg/dL)和胸部 X 线浸润(≥22%)构建了 COVID-19 ARDS 预测评分(CAPS),每个预测因素赋值 1 分。

COVID-19 ARDS 预测评分(CAPS)预测 ARDS 的曲线下面积为 0.90(95%CI 0.86-0.95;<0.001)。当 CAPS 评分截断值为 2 分时,其对 ARDS 的敏感性为 100%,特异性为 75%。

由年龄、C 反应蛋白和胸部 X 线浸润面积组成的 CAPS 可预测 COVID-19 肺炎患者发生 ARDS 的情况。

相似文献

1
Risk Factors and a Scoring System to Predict ARDS in Patients with COVID-19 Pneumonia in Korea: A Multicenter Cohort Study.韩国一项多中心队列研究:预测 COVID-19 肺炎患者发生 ARDS 的危险因素和评分系统。
Dis Markers. 2021 Apr 9;2021:8821697. doi: 10.1155/2021/8821697. eCollection 2021.
2
Novel risk scoring system for predicting acute respiratory distress syndrome among hospitalized patients with coronavirus disease 2019 in Wuhan, China.中国武汉住院的 2019 年冠状病毒病患者中预测急性呼吸窘迫综合征的新型风险评分系统。
BMC Infect Dis. 2020 Dec 17;20(1):960. doi: 10.1186/s12879-020-05561-y.
3
Clinical Characteristics and Risk Factors of Acute Respiratory Distress Syndrome (ARDS) in COVID-19 Patients in Beijing, China: A Retrospective Study.中国北京 COVID-19 患者急性呼吸窘迫综合征(ARDS)的临床特征和危险因素:一项回顾性研究。
Med Sci Monit. 2020 Sep 25;26:e925974. doi: 10.12659/MSM.925974.
4
Characterisation and outcomes of ARDS secondary to pneumonia in patients with and without SARS-CoV-2: a single-centre experience.肺炎导致的急性呼吸窘迫综合征在伴有和不伴有 SARS-CoV-2 的患者中的特征和结局:单中心经验。
BMJ Open Respir Res. 2020 Nov;7(1). doi: 10.1136/bmjresp-2020-000731.
5
A Quantitative and Radiomics approach to monitoring ARDS in COVID-19 patients based on chest CT: a retrospective cohort study.基于胸部 CT 的定量和影像组学方法监测 COVID-19 患者 ARDS:一项回顾性队列研究。
Int J Med Sci. 2020 Jul 6;17(12):1773-1782. doi: 10.7150/ijms.48432. eCollection 2020.
6
Risk factors analysis of COVID-19 patients with ARDS and prediction based on machine learning.基于机器学习的 COVID-19 合并 ARDS 患者风险因素分析及预测
Sci Rep. 2021 Feb 3;11(1):2933. doi: 10.1038/s41598-021-82492-x.
7
[Acute severe respiratory distress in chronic haemodialytic patients affected by SARS-CoV-2 pneumonia: prevalence and associated factors. A single-centre experience from Cardarelli Hospital in Naples (Italy)].[感染新型冠状病毒肺炎的慢性血液透析患者的急性重度呼吸窘迫:患病率及相关因素。意大利那不勒斯卡雷利医院的单中心经验]
G Ital Nefrol. 2021 Dec 16;38(6):2021-vol6.
8
Initial clinical characteristics of gravid severe acute respiratory syndrome coronavirus 2-positive patients and the risk of progression to severe coronavirus disease 2019.孕妇严重急性呼吸综合征冠状病毒 2 阳性患者的初始临床特征及进展为 2019 年冠状病毒病重症的风险。
Am J Obstet Gynecol MFM. 2021 Jul;3(4):100365. doi: 10.1016/j.ajogmf.2021.100365. Epub 2021 Apr 2.
9
eARDS: A multi-center validation of an interpretable machine learning algorithm of early onset Acute Respiratory Distress Syndrome (ARDS) among critically ill adults with COVID-19.eARDS:一种可解释的机器学习算法对 COVID-19 危重症成人早期急性呼吸窘迫综合征(ARDS)的多中心验证。
PLoS One. 2021 Sep 24;16(9):e0257056. doi: 10.1371/journal.pone.0257056. eCollection 2021.
10
Clinical features and risk factors associated with acute respiratory distress syndrome in pregnant women diagnosed with COVID-19: a multi-center case-control study.与 COVID-19 孕妇中急性呼吸窘迫综合征相关的临床特征和危险因素:一项多中心病例对照研究。
J Matern Fetal Neonatal Med. 2022 Dec;35(25):4884-4888. doi: 10.1080/14767058.2021.1872062. Epub 2021 Feb 8.

引用本文的文献

1
Development and Validation of an Acute Respiratory Distress Syndrome Prediction Model in Coronavirus Disease 2019: Updated Lung Injury Prediction Score.新型冠状病毒疾病中急性呼吸窘迫综合征预测模型的建立与验证:更新的肺损伤预测评分。
Mayo Clin Proc. 2023 May;98(5):736-747. doi: 10.1016/j.mayocp.2022.11.021. Epub 2022 Dec 30.
2
Higher Risk of Acute Respiratory Distress Syndrome and Risk Factors among Patients with COVID-19: A Systematic Review, Meta-Analysis and Meta-Regression.新型冠状病毒肺炎患者急性呼吸窘迫综合征的发病风险及危险因素:系统评价、荟萃分析和荟萃回归。
Int J Environ Res Public Health. 2022 Nov 16;19(22):15125. doi: 10.3390/ijerph192215125.
3

本文引用的文献

1
Dexamethasone in Hospitalized Patients with Covid-19.地塞米松在 COVID-19 住院患者中的应用。
N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.
2
Remdesivir for the Treatment of Covid-19 - Final Report.瑞德西韦治疗 COVID-19 的疗效 - 最终报告。
N Engl J Med. 2020 Nov 5;383(19):1813-1826. doi: 10.1056/NEJMoa2007764. Epub 2020 Oct 8.
3
Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage.中性粒细胞与淋巴细胞比值可预测 2019 冠状病毒病重症患者的早期病情。
The Role of Neutrophil-to-Lymphocyte Ratio in Risk Stratification and Prognostication of COVID-19: A Systematic Review and Meta-Analysis.
中性粒细胞与淋巴细胞比值在COVID-19风险分层和预后评估中的作用:一项系统评价和荟萃分析
Vaccines (Basel). 2022 Aug 1;10(8):1233. doi: 10.3390/vaccines10081233.
4
Quantitative Measurement of Pneumothorax Using Artificial Intelligence Management Model and Clinical Application.基于人工智能管理模型的气胸定量测量及其临床应用
Diagnostics (Basel). 2022 Jul 29;12(8):1823. doi: 10.3390/diagnostics12081823.
5
Development and Validation of a Nomogram for Predicting the Risk of Coronavirus-Associated Acute Respiratory Distress Syndrome: A Retrospective Cohort Study.预测冠状病毒相关急性呼吸窘迫综合征风险的列线图的开发与验证:一项回顾性队列研究
Infect Drug Resist. 2022 May 2;15:2371-2381. doi: 10.2147/IDR.S348278. eCollection 2022.
J Transl Med. 2020 May 20;18(1):206. doi: 10.1186/s12967-020-02374-0.
4
Plasma CRP level is positively associated with the severity of COVID-19.血浆 CRP 水平与 COVID-19 的严重程度呈正相关。
Ann Clin Microbiol Antimicrob. 2020 May 15;19(1):18. doi: 10.1186/s12941-020-00362-2.
5
Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19.开发和验证一种临床风险评分,以预测 COVID-19 住院患者发生危重症的情况。
JAMA Intern Med. 2020 Aug 1;180(8):1081-1089. doi: 10.1001/jamainternmed.2020.2033.
6
Risk Factors Associated With Clinical Outcomes in 323 Coronavirus Disease 2019 (COVID-19) Hospitalized Patients in Wuhan, China.中国武汉 323 例新型冠状病毒病(COVID-19)住院患者临床结局的相关危险因素分析。
Clin Infect Dis. 2020 Nov 19;71(16):2089-2098. doi: 10.1093/cid/ciaa539.
7
Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis.危重症和死亡 COVID-19 病例的风险因素:系统文献回顾和荟萃分析。
J Infect. 2020 Aug;81(2):e16-e25. doi: 10.1016/j.jinf.2020.04.021. Epub 2020 Apr 23.
8
D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19.入院时 D-二聚体水平预测 COVID-19 患者住院死亡率。
J Thromb Haemost. 2020 Jun;18(6):1324-1329. doi: 10.1111/jth.14859.
9
Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China.中国武汉 COVID-19 患者疾病严重程度、无改善和死亡率的危险因素。
Clin Microbiol Infect. 2020 Jun;26(6):767-772. doi: 10.1016/j.cmi.2020.04.012. Epub 2020 Apr 15.
10
Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan.武汉成人 COVID-19 住院患者严重程度和死亡率的危险因素。
J Allergy Clin Immunol. 2020 Jul;146(1):110-118. doi: 10.1016/j.jaci.2020.04.006. Epub 2020 Apr 12.